首页 | 本学科首页   官方微博 | 高级检索  
检索        

冠状动脉支架置入术后不同类型支架再狭窄形式分析
引用本文:金琴花,盖鲁粤,杨庭树,王禹,刘宏斌,陈练.冠状动脉支架置入术后不同类型支架再狭窄形式分析[J].中国动脉硬化杂志,2008,16(3):230-232.
作者姓名:金琴花  盖鲁粤  杨庭树  王禹  刘宏斌  陈练
作者单位:中国人民解放军总医院心内科,北京市,100853
摘    要:目的通过分析冠状动脉支架置入后造影复查的影像资料,寻找不同支架再狭窄的特点。方法入选行冠状动脉病变介入治疗后造影复查的846处病变,对再狭窄病变行再狭窄形式分析。结果裸支架和药物支架再狭窄中支架近端局限性再狭窄分别占5.69%和33.67%(P=0.000),而支架内弥漫性再狭窄分别占29.27%和9.18%(P=0.000),弥漫性狭窄累及支架两端的分别为20.33%和6.12%(P=0.003),闭塞性再狭窄发生率分别为9.76%和10.20%(P=0.912)。雷帕霉素及其衍生物释放支架和紫杉醇释放支架再狭窄支架边缘局限性再狭窄分别为47.06%和25.00%(P=0.037),支架内弥漫性狭窄分别为1.96%和16.67%(P=0.018)。结论药物支架改变了支架再狭窄模式,弥漫型转为局限型;闭塞性再狭窄时药物支架以支架近端闭塞为主,裸支架以支架内闭塞为主;紫杉醇药物释放支架弥漫性再狭窄发生率较雷帕霉素释放支架有所增加。

关 键 词:内科学  经皮冠状动脉介入治疗  药物支架  再狭窄  雷帕霉素  紫杉醇
文章编号:1007-3949(2008)16-03-0230-03
收稿时间:2007/8/22 0:00:00
修稿时间:2007年8月22日

Coronary Restenosis Morphology After Intracoronary Interventional Therapy
JIN Qin-Hu,GAI Lu-Yue,YANG Ting-Shu,WANG Yu,LIU Hong-Bin,and CHEN-Lian.Coronary Restenosis Morphology After Intracoronary Interventional Therapy[J].Chinese Journal of Arteriosclerosis,2008,16(3):230-232.
Authors:JIN Qin-Hu  GAI Lu-Yue  YANG Ting-Shu  WANG Yu  LIU Hong-Bin  and CHEN-Lian
Institution:Cardiovascular Department,Chinese People''s Liberation Army General Hospital,Beijing 100853,China
Abstract:Aim To evaluate the morphology of in-stent restenosis after different kinds of stents. Methods 846 lesions of patients who performed intracoronary interventional therapy and had angiographic follow-up in our cath lab were included in this study.Restenosis types of different drug eluting stents(DES) were analysed too. Results The focal proximal edge restenosis was 5.69% and 33.67% in bare mental stent(BMS) and DES respectively(P=0.000);Whereas the diffuse lesion in stent was 29.27% and 9.18%(P=0.000);Proliferative restenosis was 20.33% and 6.12%(P=0.003);The rate of total occlusion restenosis was 9.76% and 10.20%(P=0.912),while in DES the occlusion formed at proximal segment,and in BMS it formed in stent;Focal proximal edge restenois lesion was 47.06% and 25.00% in sirolimus eluting stent and taxol eluting stent(P=0.037);The diffuse in stent restenosis was 1.96% and 16.67%(P=0.018). Conclusion DES changed the morphology of in-stent restenosis,from diffuse restenosis to focal restenosis;Total occlusion restenosis rate in two different stents were same,but occlusion formed at proximal segment more commonly in DES while at in-stent in BMS;The diffuse restenosis lesion were common in taxus stent than that in other DES.
Keywords:Percutaneous Coronary Intervention  Drug Eluting Stent  Restenosis  Sirolimus  Paxlitaxol
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《中国动脉硬化杂志》浏览原始摘要信息
点击此处可从《中国动脉硬化杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号